<DOC>
	<DOCNO>NCT00245453</DOCNO>
	<brief_summary>To measure speed bacterial eradication respiratory tract administration azithromycin telithromycin .</brief_summary>
	<brief_title>Outpatient Registry Trial Respiratory Tract Infections Adults</brief_title>
	<detailed_description>To Evaluate relationship rate S. pneumoniae kill sputum , PK/PD , clinical response oral telithromycin azithromycin patient AECB CAP determine difference rate infection site bacterial killing ( describe ) 3 antibiotic penicillin- erythromycin-resistant S.pneumoniae</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Telithromycin</mesh_term>
	<criteria>Adult patient , either male nonpregnant female , age 18 75 year age clinical finding CAP AECB amenable serial nasopharyngeal oropharyngeal sample positive BinaxNOW test indicate infection Streptococcus pneumoniae Patients medical history clinical finding consistent respiratory tract infection . A patient advanced COPD , repeat exacerbation history , BINAXNOW test consistent S. pneumoniae and/or proven culture positivity S. pneumoniae may enrol All patient ( CAP AECB ) must produce purulent sputum positive Urinary BINAXNOW assay . The female patient child bear potential must agree use accepted method contraception ( i.e. , oral implant contraceptive barrier method , spermicide barrier method , IUD ) . The patient must agree continue method throughout study . Baseline sputum culture know negative S. pneumoniae , negative urinary BINAXNOW . Patients microbiologically document pathogen know prior inclusion resistant study medication . History hypersensitivity macrolides , azalides , ketolide antibiotic history serious hypersensitivity reaction drug . Preexisting impaired hepatic function impair renal function CCL &lt; 20ml/min Patients require onstudy treatment medication know contraindicated drug interaction telithromycin Treatment one dose antimicrobial prior entry study Others per protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>pneumonia</keyword>
	<keyword>Spneumoniae</keyword>
	<keyword>bronchitis</keyword>
	<keyword>telithromycin</keyword>
	<keyword>azithromycin</keyword>
</DOC>